Dual Actions of Butyrate on Immunoepithelial Remodeling in Ex Vivo Intestinal Biopsies from Patients with Inflammatory Bowel Disease
Metabolites · 06.06.2026 · 16 (6) · 395
DOI: 10.3390/metabo16060395 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 06.06.2026. Verfasst von Sara Troisi und 14 weiteren Autor:innen. Beteiligte Einrichtung: CeMAD Translational Research Laboratories, Digestive Disease Center (CeMAD), Department of Medical and Surgical Sciences, Fondazione Policlinico Univ…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Butyrate, a microbiota-derived short-chain fatty acid, plays a central role in intestinal homeostasis, yet its concentration-dependent effects on human inflamed mucosa remain poorly defined. This study investigates the dose-dependent impact of butyrate on inflammatory signaling and epithelial architecture in ex vivo intestinal biopsies from patients with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD).
Methods
Intestinal biopsies from six IBD patients (four UC, two CD) were cultured ex vivo for 24 h with calcium butyrate (5, 10, 100 mM). Cytokine secretion was analyzed by multiplex immunoassay, total protein release was quantified, and glandular morphology was assessed by stereological analysis.
Results
Butyrate was associated with a dose-dependent reduction in pro-inflammatory cytokines-including TNF-α, IFN-γ, IL-6, and IL-17-in both inflamed and non-inflamed tissue. Non-linear responses were observed for specific mediators, such as IP-10, which displayed a biphasic pattern in inflamed UC biopsies. Notably, UC and CD biopsies exhibited distinct response profiles: UC samples showed marked cytokine modulation, including reduction in IL-15, whereas CD samples, evaluated at 5 and 10 mM, showed limited modulation across conditions. A trend toward reduced total protein secretion was observed in diseased UC biopsies following butyrate exposure. Stereological analysis revealed preservation of glandular area at 5 mM, reduction at 10 mM, and extensive tissue disruption at 100 mM precluding structural evaluation.
Conclusions
In this pilot study, butyrate exerts dose-dependent and disease-specific effects in human IBD mucosa within a narrow therapeutic window. These exploratory findings suggest that dose-optimized strategies for butyrate-based interventions may be particularly relevant in UC, although larger confirmatory studies are needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CeMAD Translational Research Laboratories, Digestive Disease Center (CeMAD), Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy.
- Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Histopathology Unit, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy.
- Center for Advanced Studies and Technology (CAST), Department of Medicine and Aging Science, G. D'Annunzio University of Chieti-Pescara, 66100 Chieti, Italy.
- IBD Unit, Digestive Disease Center (CeMAD), Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, 00168 Rome, Italy.
- Department of Life Science, Health, and Health Professions, Link Campus University, 00168 Rome, Italy.
ORCID-Profile: Sara Troisi, Cesare Pane, Letizia Masi, Filippo Biamonte, Antonio Cappa Spina, Miriam Di Mattia, Valeria Emoli, Ivan Capobianco, Sonia Distante, Barbara Rondinone, Valentina Petito, Antonio Gasbarrini, Franco Scaldaferri
Zitieren
APA
Troisi, S., Pane, C., Masi, L., Biamonte, F., Scannone, D., Cappa Spina, A., Di Mattia, M., Emoli, V., Capobianco, I., Distante, S., Rondinone, B., Petito, V., Gasbarrini, A., Lopetuso, L. R., & Scaldaferri, F. (2026). Dual Actions of Butyrate on Immunoepithelial Remodeling in Ex Vivo Intestinal Biopsies from Patients with Inflammatory Bowel Disease. Metabolites, 16(6), 395. https://doi.org/10.3390/metabo16060395
Vancouver
Troisi S, Pane C, Masi L, Biamonte F, Scannone D, Cappa Spina A, et al. Dual Actions of Butyrate on Immunoepithelial Remodeling in Ex Vivo Intestinal Biopsies from Patients with Inflammatory Bowel Disease. Metabolites. 2026;16(6):395. doi:10.3390/metabo16060395
BibTeX
@article{Troisi2026,
author = {Troisi, Sara and Pane, Cesare and Masi, Letizia and Biamonte, Filippo and Scannone, Domenico and Cappa Spina, Antonio and Di Mattia, Miriam and Emoli, Valeria and Capobianco, Ivan and Distante, Sonia and Rondinone, Barbara and Petito, Valentina and Gasbarrini, Antonio and Lopetuso, Loris Riccardo and Scaldaferri, Franco},
title = {Dual Actions of Butyrate on Immunoepithelial Remodeling in Ex Vivo Intestinal Biopsies from Patients with Inflammatory Bowel Disease},
journal = {Metabolites},
year = {2026},
volume = {16},
number = {6},
pages = {395},
doi = {10.3390/metabo16060395}
}
EUVIMED